Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224486

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224486

Liquid Biopsy Market with COVID-19 Impact Analysis, By Sample, By Biomarker, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

PUBLISHED:
PAGES: 355 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF (Enterprise User License)
USD 5650

Add to Cart

Contact us about how to customize the report with add-on data.

REPORT HIGHLIGHT

Liquid Biopsy Market size was valued at USD 4,404.7 Million in 2022, expanding at a CAGR of 20.1% from 2023 to 2030.

Liquid biopsy is a minimally invasive alternative to surgical biopsies that enables medical professionals to learn more about a tumor from a blood sample and customize the therapy accordingly. It can give a solid foundation for customized therapy and reflect changes in the gene expression profile of the tumor. Early diagnostic screening, tumor heterogeneity, and medication resistance are all aided by it. In addition to this, it also finds EGFR gene mutations, which are common in non-small cell lung cancer patients (NSCLC).

Liquid Biopsy Market- Market Dynamics

The number of cancer patients worldwide is growing as a result of sedentary lifestyles and increased cigarette use. One of the primary factors influencing the market is the rising knowledge among people about sophisticated minimally invasive (MI) techniques in cancer diagnoses. Furthermore, to promote the introduction of cutting-edge cancer treatments, the governments of numerous nations are funding research and development (R&D) projects. These institutions also make large investments in the growth of the healthcare sector, which provides key competitors in the market with attractive chances for expansion.

In addition, major market participants are concentrating on product introductions to expand customized medicine globally. To improve the workflow and results of the liquid biopsy method, they are also incorporating technological developments. This is helping to drive the industry along with the increasing use of blood-based biopsy diagnostics for early tumor identification. The need for liquid biopsy is also being fueled by the growing use of exosomes for clinical diagnosis of cancer due to their high accuracy and quick turnaround times. Rapid advancements in digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) technology are expected to drive the market's expansion.

Liquid Biopsy Market- Segmentation Analysis:

Based on the sample, blood sample-based tests are expected to dominate the market during the forecast period. A blood test is non-invasive, risk-free, and painless. Additionally, it decreases the expense and length of the diagnostic process. The detection of CTCs, cfDNAs, exosomes, and microvesicles in the blood sample has increased the use of blood-based liquid biopsy. Moreover, Understanding carcinogenesis and metastasis are largely dependent on the circulating biomarkers in blood, which may also be used to predict tumor dynamics throughout therapy and disease progression. Additionally, the market is anticipated to be driven by increasing research on blood-based cancer testing. For instance, a research team at Exact Sciences and UW-Madison began developing liquid biopsies for cancer in August 2021. One of these liquid biopsies is a blood test that can assist identify genetic abnormalities in tumors that are the focus of medication treatments. This test aids in the early diagnosis of the disease and can identify cancer recurrence following therapy.

Based on the technology, the Multi-gene-parallel Analysis (NGS) segment is expected to hold the largest market share during the forecast period. NGS technology may identify a wide range of mutations that can contribute to carcinogenesis as well as identify potential resistance mechanisms that might have emerged from pre-existing clones following therapy. Recent fast advancements in NGS technology have resulted in a considerable cost decrease for high-accuracy sequencing. This approach enables the screening of unidentified variations and is employed in focused panels for the precise and extremely sensitive identification of ctDNA mutations. For instance, 59% of patients with stage 1 or stage 2 lung cancer may be found using NGS with a MAF of 0.1%.

Liquid Biopsy Market- Geographical Insights

North America is expected to dominate the market during the forecast period. Due to higher investments and the existence of several biotechnology businesses producing the tests, the U.S. dominates the regional market. Liquid biopsy is supported by several organizations, including the American Society of Clinical Oncology (ASCO). In consequence, it is projected that this would accelerate market expansion in this region. Since tests that have received FDA approval may be utilized there, Canada has followed the United States in adopting liquid biopsy procedures. Additionally, the industry is highly competitive, which is anticipated to fuel market expansion throughout the forecast period. The government's increased grants and investments in the development of liquid biopsy tests are anticipated to raise demand in the nation.

Key features of the study:

This proposed research study on the Liquid Biopsy market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for ` the Liquid Biopsy market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Liquid Biopsy market

The impact of COVID-19 on the Liquid Biopsy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Liquid Biopsy market post-COVID will also be covered.

To give the users of this report a comprehensive view of the Liquid Biopsy market, we have also included a competitive landscape and key innovator analysis for the Liquid Biopsy market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Liquid Biopsy market.

In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.

The global Liquid Biopsy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIQUID BIOPSY MARKET KEY PLAYERS

F. Hoffmann-La Roche Ltd.

Thermo Fisher Scientific, Inc.

BIOCEPT, Inc.

Guardant Health, Inc.

QIAGEN

Illumina, Inc.

Angle plc

Oncimmune

Myriad Genetics, Inc.

Lucence health Inc.

EPIGENOMICS AG

FreenomeHoldings, Inc.

GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE

Blood Sample-based

Others

GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER

Circulating Nucleic Acids

CTC

Exosomes/Microvesicles

Circulating Proteins

GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY

Multi-gene-parallel Analysis (NGS)

Single Gene Analysis (PCR Microarrays)

GLOBAL LIQUID BIOPSY MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

Product Code: ANV1125

TABLE OF CONTENT

1. Liquid Biopsy Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Liquid Biopsy Market Snippet by Sample
    • 2.1.2. Liquid Biopsy Market Snippet by Biomarker
    • 2.1.3. Liquid Biopsy Market Snippet by Technology
    • 2.1.4. Liquid Biopsy Market Snippet by Country
    • 2.1.5. Liquid Biopsy Market Snippet by Region
  • 2.2. Competitive Insights

3. Liquid Biopsy Key Market Trends

  • 3.1. Liquid Biopsy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Liquid Biopsy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Liquid Biopsy Market Opportunities
  • 3.4. Liquid Biopsy Market Future Trends

4. Liquid Biopsy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Liquid Biopsy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Liquid Biopsy Market Landscape

  • 6.1. Liquid Biopsy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Liquid Biopsy Market - By Sample

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Sample, 2022 & 2030 (%)
    • 7.1.2. Blood Sample-based
    • 7.1.3. Others

8. Liquid Biopsy Market - By Biomarker

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Biomarker, 2022 & 2030 (%)
    • 8.1.2. Circulating Nucleic Acids
    • 8.1.3. CTC
    • 8.1.4. Exosomes/Microvesicles
    • 8.1.5. Circulating Proteins

9. Liquid Biopsy Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 9.1.2. Multi-gene-parallel Analysis (NGS)
    • 9.1.3. Single Gene Analysis (PCR Microarrays)

10. Liquid Biopsy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Liquid Biopsy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Liquid Biopsy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Liquid Biopsy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Liquid Biopsy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Liquid Biopsy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Liquid Biopsy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. Thermo Fisher Scientific, Inc.
    • 11.2.3. BIOCEPT, Inc.
    • 11.2.4. Guardant Health, Inc.
    • 11.2.5. QIAGEN
    • 11.2.6. Illumina, Inc.
    • 11.2.7. Angle plc
    • 11.2.8. Oncimmune
    • 11.2.9. Myriad Genetics, Inc.
    • 11.2.10. Lucence health Inc.
    • 11.2.11. EPIGENOMICS AG
    • 11.2.12. FreenomeHoldings, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
Product Code: ANV1125

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liquid Biopsy Market:Sample Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Sample
  • TABLE Global Liquid Biopsy Market, by Sample 2018-2030 (USD Million)
  • TABLE Liquid Biopsy Market: Biomarker Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Biomarker
  • TABLE Global Liquid Biopsy Market, by Biomarker 2018-2030 (USD Million)
  • TABLE Liquid Biopsy Market: Regional snapshot (2022)
  • TABLE Liquid Biopsy Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Liquid Biopsy Market, by Technology 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liquid Biopsy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Liquid Biopsy Market, by Sample, 2018-2030 (USD Million)
  • TABLE North America Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
  • TABLE North America Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Liquid Biopsy Market, by Sample, 2018-2030 (USD Million)
  • TABLE Europe Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
  • TABLE Europe Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy Market, by Sample, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Liquid Biopsy Market, by Sample, 2018-2030 (USD Million)
  • TABLE Latin America Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
  • TABLE Latin America Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liquid Biopsy Market, by Sample, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)

List of Figures

  • FIGURE Liquid Biopsy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Sample segment market share analysis, 2022 & 2030
  • FIGURE Sample segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Biomarker segment market share analysis, 2022 & 2030
  • FIGURE Biomarker segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Liquid Biopsy Market share and leading players, 2022
  • FIGURE Europe Liquid Biopsy Market share and leading players, 2022
  • FIGURE Asia Pacific Liquid Biopsy Market share and leading players, 2022
  • FIGURE Latin America Liquid Biopsy Market share and leading players, 2022
  • FIGURE Middle East and Africa Liquid Biopsy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Liquid Biopsy Market share analysis by country, 2022
  • FIGURE Germany Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Liquid Biopsy Market share analysis by country, 2022
  • FIGURE India Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liquid Biopsy Market share analysis by country, 2022
  • FIGURE Brazil Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liquid Biopsy Market share analysis by country, 2022
  • FIGURE Saudi Arabia Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Liquid Biopsy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!